Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin vs. UFH as Bridging Therapy in Embolic Stroke
NCT02159287Phase 2Unknown
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2014
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of enoxaparin in embolic stroke, sponsored by Shiraz University of Medical Sciences. Status: unknown.
02
Drugs
enoxaparin
03
Conditions
embolic stroke
Beyond the preview
Go deeper on NCT02159287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02159287.